|
MCM9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63309999967609E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.50749999652911E-08 |
| Normal-vs-Stage2 |
1.079800E-03 |
| Normal-vs-Stage3 |
1.478760E-03 |
| Normal-vs-Stage4 |
1.055720E-02 |
| Stage1-vs-Stage2 |
4.649200E-01 |
| Stage1-vs-Stage3 |
3.174000E-01 |
| Stage1-vs-Stage4 |
5.866200E-01 |
| Stage2-vs-Stage3 |
9.011200E-01 |
| Stage2-vs-Stage4 |
9.953200E-01 |
| Stage3-vs-Stage4 |
9.298200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.55949999972138E-07 |
| Normal-vs-AfricanAmerican |
1.95369999999029E-05 |
| Normal-vs-Asian |
1.403600E-02 |
| Caucasian-vs-AfricanAmerican |
9.238400E-01 |
| Caucasian-vs-Asian |
9.313400E-01 |
| AfricanAmerican-vs-Asian |
8.958200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.713499951985E-09 |
| Normal-vs-Female |
1.303730E-02 |
| Male-vs-Female |
9.620000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.777500E-04 |
| Normal-vs-Extreme_Weight |
1.36919999782492E-08 |
| Normal-vs-Obese |
1.005770E-04 |
| Normal-vs-Extreme_Obese |
1.775470E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.325800E-02 |
| Normal_Weight-vs-Obese |
9.577600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.170600E-01 |
| Extreme_Weight-vs-Obese |
1.274050E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.305000E-01 |
| Obese-vs-Extreme_Obese |
5.185600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.336000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.14939999999553E-05 |
| Normal-vs-Age(61-80Yrs) |
1.54790000039817E-07 |
| Normal-vs-Age(81-100Yrs) |
5.51409999993702E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.662600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.177700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.764400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.121800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.577400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.161000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.5203999998169E-08 |
| Normal-VS-Type2 PRCC |
1.93320000008157E-07 |
| Normal-VS-KIRP CIMP |
7.370400E-02 |
| Normal-VS-Unclassified PRCC |
1.936320E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.196000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.620020E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.009600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.405800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.781800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.464400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.39999997653229E-09 |
| Normal-vs-N1 |
2.289400E-01 |
| Normal-vs-N2 |
7.646800E-04 |
| N0-vs-N1 |
1.985880E-02 |
| N0-vs-N2 |
3.782400E-01 |
| N1-vs-N2 |
1.376780E-01 |
|
|
